New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billions

A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup